Volume 10, Issue 1 (3-2022)                   JoMMID 2022, 10(1): 10-13 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Dasgupta S, Chakraborty O. Mycobacterium tuberculosis Dominance over Nontuberculous Mycobacteria Irrespective of Immune Status: An Indian Scenario. JoMMID 2022; 10 (1) :10-13
URL: http://jommid.pasteur.ac.ir/article-1-415-en.html
Mycobacterium tuberculosis Dominance over Nontuberculous Mycobacteria Irrespective of Immune Status: An Indian Scenario
Soumya Dasgupta , Oindrila Chakraborty
MJN Medical College and Hospital, Coochbehar. West Bengal. India. Zip – 736101
Abstract:   (1166 Views)
Introduction: In HIV-associated tuberculosis cases, identifying nontuberculous Mycobacteria (NTM) from clinical samples has become essential regarding patients’ treatment and prognosis. This study aims to determine the prevalence of different Mycobacteria species from immunocompromised and immunocompetent patients with suspected tuberculosis attending a tertiary care hospital in Kolkata, India. Methods: Clinical samples from 112 suspected tuberculosis patients were examined by direct microscopy after Ziehl–Neelsen staining. After culture in BacT/ALERT 3D mycobacterial culture system, identification of the causative agents was performed using the GenoType MTCM system. Results: Culture positivity was higher in immunocompromised patients than in immunocompetent in both pulmonary and extrapulmonary samples. In smear-negative samples, culture positivity in immunocompromised patients (50%) was much higher than in immunocompetent patients (26.67%). Of 78 samples, four were NTMs (5.13%), including 1 M. avium, 1 M. abscessus, and 2 M. fortuitum, and 74 were Mycobacterium tuberculosis (MTBC). Two NTMs belonged to immunocompromised patients and two to immunocompetent individuals. The chance of Mycobacterial infection was higher in patients with a lower CD4 count. Both NTMs found in the immunocompromised group were from patients with a CD4 count<100. Conclusion: The present study showed that the MTBC is still the primary causative agent in pulmonary and extrapulmonary tuberculosis in this part of India.
Keywords: Tuberculosis, NTM, Immunocompromised, CD4 count.
Full-Text [PDF 635 kb]   (581 Downloads)    
Type of Study: Original article | Subject: Epidemiologic studies including microbial genotyping, phenotyping and serotyping
Received: 2021/10/18 | Accepted: 2022/03/11 | Published: 2022/04/4
References
1. Marras TK, Daley CL. Epidemiology of human pulmonary infection with non-tuberculous mycobacteria. Clin Chest Med. 2002; 23: 553-67. [DOI:10.1016/S0272-5231(02)00019-9]
2. Set R, Shastri J. Laboratory aspects of clinically significant rapidly growing mycobacteria. Indian J Med Microbiol. 2011; 29: 343-52. [DOI:10.4103/0255-0857.90157]
3. Winthrop KL, Mcnelley E, Kendall B, et al. Pulmonary non-tuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010; 182: 977-82. [DOI:10.1164/rccm.201003-0503OC]
4. McCarthy KD, Cain KP, Winthrop KL, et al. Non-tuberculous mycobacterial disease in patients with HIV in Southeast Asia. Am J Resp Crit Care Med. 2012; 185: 981-8. [DOI:10.1164/rccm.201107-1327OC]
5. Miguez-Burbano MJ, Flores M, Ashkin D, Rodriguez A, Granada AM, Quintero N, Pitchenik A. Non-tuberculous mycobacteria disease as a cause of hospitalization in HIV-infected patients. Int J Infect Dis. 2006; 10: 47-55. [DOI:10.1016/j.ijid.2004.11.005]
6. Marras TK, Morris A, Gonzalez LC, Daley CL. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus. Am J Resp Crit Care Med. 2004; 170: 793-8. [DOI:10.1164/rccm.200402-162OC]
7. Gopinath K, Singh S. Non-tuberculous Mycobacteria in TB endemic countries: are we neglecting the danger? PLoS Negl Trop Dis. 2010; 4: e615. [DOI:10.1371/journal.pntd.0000615]
8. Jani MN, Rodrigues C, Mehta AP. The neglected and often ignored: nontuberculous Mycobacteria. J Glob Infect Dis. 2011; 3: 94. [DOI:10.4103/0974-777X.77305]
9. Alvarez-Uria G, Falco V, Martin-Casabona N, et al. Non-tuberculous mycobacteria in the sputum of HIV-infected patients: infection or colonization. Int J STD AIDS 2009; 20: 193-5. [DOI:10.1258/ijsa.2008.008300]
10. Leandro Cruz Campos, Marcos Vinícius Vieira Rocha, Denise Maria Cunha Willers, and Denise Rossato Silva. Characteristics of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a Region with High TB and HIV Prevalence. PLoS One. 2016; 11 (1): e0147933 [DOI:10.1371/journal.pone.0147933]
11. Small PM, Selcer UM. Human Immunodeficiency virus and Tuberculosis. In: Schlossberg D, editor.Tuberculosis and Nontuberculous Mycobacterial Infections. 4th ed. Philadelphia: W.B Saunders Company; 1999. pp. 332-4.
12. Jesudason MV, Gladstone P. Non tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital in South India. Indian J Med Microbiol. 2005; 23 (3): 172-5. [DOI:10.1016/S0255-0857(21)02588-3]
13. Narang P, Narang Rahul, Bhattacharya S and Mendiratta DK. Paraffin slide culture technique for isolating non-tuberculous mycobacteria from clinical specimens of stool and sputum of HIV seropositive patients. Indian J Tuberc. 2004; 51: 23-6.
14. Narang P, Narang R, Mendiratta DK, Roy D, Deotale V, M. A. Yakrus, Sean T, and Kale V. Isolation of Mycobacterium avium complex and M. simiae from blood of AIDS patients from Sevagram, Maharashtra. Indian J Tuberc. 2005; 52: 21-26.
15. J O Falkinham 3rd. Epidemiology of Infection by Nontuberculous Mycobacteria Clin Microbiol Rev. 1996; 9 (2): 177-215. [DOI:10.1128/CMR.9.2.177]
16. Editorial. Relevance of Non tuberculous Mycobacteria in India. Indian Journal of Tuberculosis. 2008; 55 (4): 175-8.
17. Narang R, Narang P, Jain AP, Mendiratta DK, Wankhade A, Joshi R, et al. International J Tuberc Lung Dis. 2007; (supplement).
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.